Microarray profiling of antibody responses against simian-human immunodeficiency virus: Postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 11125-11138

  De Vegvar, Henry E Neuman ^a,b   Amara, Rama Rao ^c   Steinman, Lawrence ^a   Utz, Paul J ^a   Robinson, Harriet L ^c   Robinson, William H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; GAG PROTEIN; POL PROTEIN; UNCLASSIFIED DRUG; VACCINIA ANKARA VACCINE; VACCINIA VACCINE; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA MICROARRAY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS; VACCINIA VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; FUSION PROTEINS, GAG-POL; HIV-1; MACACA; MOLECULAR SEQUENCE DATA; PROTEIN ARRAY ANALYSIS; PROTEOME; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0141565124     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.11125-11138.2003     Document Type: Article

References (53)

1. Abacioglu, Y. H., T. R. Fouts, J. D. Laman, E. Claassen, S. H. Pincus, J. P. Moore, C. A. Roby, R. Kamin-Lewis, and G. K. Lewis. 1994. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retrovir. 10:371-381.
2. Ahmad, A., and J. Menezes. 1996. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10:258-266.
3. Alt, F. W., T. K. Blackwell, and G. D. Yancopoulos. 1987. Development of the primary antibody repertoire. Science 238:1079-1087.
4. Amara, R. R., and H. L. Robinson. 2002. A new generation of HIV vaccines. Trends Mol. Med. 8:489-495.
5. Amara, R. R., J. M. Smith, S. I. Staprans, D. C. Montefiori, F. Villinger, J. D. Altman, S. P. O'Neil, N. L. Kozyr, Y. Xu, L. S. Wyatt, P. L. Earl, J. G. Herndon, J. M. McNicholl, H. M. McClure, B. Moss, and H. L. Robinson. 2002. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J. Virol. 76:6138-6146.
6. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2002. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Vaccine 20:1949-1955.
7. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
8. Amara, R. R., F. Villinger, S. I. Staprans, J. D. Altman, D. C. Montefiori, N. L. Kozyr, Y. Xu, L. S. Wyatt, P. L. Earl, J. G. Herndon, H. M. McClure, B. Moss, and H. L. Robinson. 2002. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. J. Virol. 76:7625-7631.
9. Baba, T. W., V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L. A. Cavacini, M. R. Posner, H. Katinger, G. Stiegler, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, Y. Lu, J. E. Wright, T. C. Chou, and R. M. Ruprecht. 2000. Hum. neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206.
10. Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Lifton, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M. E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, M. G. Lewis, E. A. Emini, J. W. Shiver, and N. L. Letvin. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486-492.
11. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
12. Burton, D. R. 2002. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2:706-713.
13. Campioni, D., A. Corallini, G. Zauli, L. Possati, G. Altavilla, and G. Barbanti-Brodano. 1995. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res. Hum. Retroviruses 11:1039-1048.
14. Carrow, E. W., L. K. Vujcic, W. L. Glass, K. B. Seamon, S. C. Rastogi, R. M. Hendry, R. Boulos, N. Nzila, and G. V. Quinnan, Jr. 1991. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas. AIDS Res. Hum. Retroviruses 7:831-838.
15. Cohn, M., and R. E. Langman. 1990. The protecton: the unit of humoral immunity selected by evolution. Immunol. Rev. 115:11-147.
16. D'Souza, M. P., P. Durda, C. V. Hanson, G. Milman, et al. 1991. Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. AIDS 5:1061-1070.
17. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
18. Evans, D. J., J. McKeating, J. M. Meredith, K. L. Burke, K. Katrak, A. John, M. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. 1989. An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339:385-388.
19. Geysen, H. M., R. H. Meloen, and S. J. Barteling. 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81:3998-4002.
20. Gnann, J. W., Jr., P. L. Schwimmbeck, J. A. Nelson, A. B. Truax, and M. B. Oldstone. 1987. Diagnosis of AIDS by with a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J. Infect. Dis. 156:261-267.
21. Goudsmit, J., R. H. Meloen, and R. Brasseur. 1990. Map of sequential B-cell epitopes of the HIV-1 transmembrane protein with human antibodies as probe. Intervirology 31:327-338.
22. Goulder, P. J., S. L. Rowland-Jones, A. J. McMichael, and B. D. Walker. 1999. Anti-HIV cellular immunity: recent advances towards vaccine design. AIDS 13:S121-136.
23. Grandgenett, D. P., and G. Goodarzi. 1994. Folding of the multidomain human immunodeficiency virus type-I integrase. Protein Sci. 3:888-897.
24. Haab, B. B., M. J. Dunham, and P. O. Brown. 22 January 2001, posting date. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2. [Online.]
25. Hinkula, J., C. Svanholm, S. Schwartz, P. Lundholm, M. Brytting, G. Engstrom, R. Benthin, H. Glaser, G. Sutter, B. Kohleisen, V. Erfle, K. Okuda, H. Wigzell, and B. Wahren. 1997. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J. Virol. 71:5528-5539.
26. + lymphocyte depletion in rhesus monkeys. J. Virol. 71:4218-4225.
27. Kennedy, R. C., R. D. Henkel, D. Pauletti, J. S. Allan, T. H. Lee, M. Essex, and G. R. Dreesman. 1986. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science 231:1556-1559.
28. Kent, K. A., L. Gritz, G. Stallard, M. P. Cranage, C. Collignon, C. Thiriart, T. Corcoran, P. Silvera, and E. J. Stott. 1991. Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 5:829-836.
29. Korber, B. T. M., C. Brander, B. F. Haynes, R. A. Koup, C. Kuiken, J. P. Moore, B. D. Walker, and D. I. Watkins (ed.). 2001. HIV molecular immunology 2001. Los Alamos National Laboratory, Theoretical Biology and Biophysics Group T-10, Los Alamos, N.Mex.
30. Li, J. T., M. Halloran, C. I. Lord, A. Watson, J. Ranchalis, M. Fung, N. L. Letvin, and J. G. Sodroski. 1995. Persistent infection of macaques with simian-human immunodeficiency viruses. J. Virol. 69:7061-7067.
31. Loomis-Price, L. D., J. H. Cox, J. R. Mascola, T. C. VanCott, N. L. Michael, T. R. Fouts, R. R. Redfield, M. L. Robb, B. Wahren, H. W. Sheppard, and D. L. Birx. 1998. Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection. J. Infect. Dis. 178:1306-1316.
32. Mascola, J. R., G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
33. Nobrega, A., A. Grandien, M. Haury, L. Hecker, E. Malanchere, and A. Coutinho. 1998. Functional diversity and clonal frequencies of reactivity in the available antibody repertoire. Eur. J. Immunol. 28:1204-1215.
34. Parren, P. W., J. P. Moore, D. R. Burton, and Q. J. Sattentau. 1999. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 13:S137-162.
35. Perelygina, L., H. Zurkuhlen, I. Patrusheva, and J. K. Hilliard. 2002. Identification of a herpes B virus-specific glycoprotein D immunodominant epitope recognized by natural and foreign hosts. J. Infect. Dis. 186:453-461.
36. Pincus, S. H., K. G. Messer, R. Cole, R. Ireland, T. C. VanCott, A. Pinter, D. H. Schwartz, B. S. Graham, and G. J. Gorse. 1997. Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines. J. Immunol. 158:3511-3520.
37. Pincus, S. H., K. G. Messer, and S. L. Hu. 1994. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection. J. Clin. Investig. 93:140-146.
38. Pincus, S. H., K. G. Messer, D. H. Schwartz, G. K. Lewis, B. S. Graham, W. A. Blattner, and G. Fisher. 1993. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. J. Clin. Investig. 91:1987-1996.
39. Reimann, K. A., J. T. Li, R. Veazey, M. Halloran, I. W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.
40. Rencher, S. D., and J. L. Hurwitz. 1997. Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:69-73.
41. Robinson, W. H., C. DiGennaro, W. Hueber, B. B. Haab, M. Kamachi, E. J. Dean, S. Fournel, D. Fong, M. C. Genovese, H. E. Neuman de Vegvar, K. Skriner, D. L. Hirschberg, R. I. Morris, S. Muller, G. J. Pruijn, W. J. van Venrooij, J. S. Smolen, P. O. Brown, L. Steinman, and P. J. Utz. 2002. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8:295-301.
42. Robinson, W. H., P. Fontoura, B. J. Lee, H. E. Neuman de Vegvar, J. Tom, C. D. DiGennaro, R. Pedotti, D. J. Mitchell, D. Fong, P. P.-K. Ho, P. Ruiz, E. Maverakis, D. B. Stevens, C. C. A. Bernard, R. Martin, V. K. Kuchroo, J. M. van Noort, C. P. Genain, S. Amor, T. Olsson, P. J. Utz, H. Garren, and L. Steinman. Reverse genomics: Protein microarrays guide DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol., in press.
43. Sepkowitz, K. A. 2001. AIDS-the first 20 years. N. Engl. J. Med. 344:1764-1772.
44. Shibata, R., T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Willey, M. W. Cho, and M. A. Martin. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:204-210.
45. Storey, J. D. 2002. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B Stat. Methodol. 64:479-498.
46. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121.
47. von Brunn, A., M. Brand, C. Reichhuber, C. Morys-Wortmann, F. Deinhardt, and F. Schoedel. 1993. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles. Vaccine 11:817-824.
48. von Brunn, A., C. Reichhuber, M. Brand, B. Bechowsky, L. Guertler, J. Eberle, A. Kleinschmidt, V. Erfle, and F. Schoedel. 1993. The principal neutralizing determinant (V3) of HIV-1 induces HIV-1-neutralizing antibodies upon expression on HBcAg particles. Vaccines (Cold Spring Harbor) 93:159-165.
49. Wang, J. G., R. W. Jansen, E. A. Brown, and S. M. Lemon. 1990. Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J. Virol. 64:1108-1116.
50. Wang, J. J., S. Steel, R. Wisniewolski, and C. Y. Wang. 1986. Detection of antibodies to human T-lymphotropic virus type III by with a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc. Natl. Acad. Sci. USA. 83:6159-6163.
51. Xu, J. Y., M. K. Gorny, T. Palker, S. Karwowska, and S. Zolla-Pazner. 1991. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, with ten human monoclonal antibodies. J. Virol. 65:4832-4838.
52. Yang, O. O., and B. D. Walker. 1997. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.
53. Zwart, G., H. Langedijk, L. van der Hoek, J. J. de Jong, T. F. Wolfs, C. Ramautarsing, M. Bakker, A. de Ronde, and J. Goudsmit. 1991. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology 181:481-489.